CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Ro 48-8071 Fumarate 5mg  | ≥99%

CSNpharm

Ro 48-8071 Fumarate is an inhibitor of Oxidosqualene cyclase (OSC) with IC50 of 6.5 nM, also inhibits Ebola virus (EBOV) cell entry with IC50 of 1.74 μM and blocks cholesterol synthesis in HepG2 cells.

More Information Supplier Page

Ro 48-8071 Fumarate 50mg  | ≥99%

CSNpharm

Ro 48-8071 Fumarate is an inhibitor of Oxidosqualene cyclase (OSC) with IC50 of 6.5 nM, also inhibits Ebola virus (EBOV) cell entry with IC50 of 1.74 μM and blocks cholesterol synthesis in HepG2 cells.

More Information Supplier Page

Ro 61-8048 10mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

Ro 61-8048 5mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

Ro 61-8048 50mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

Ro 61-8048 100mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

Ro 61-8048 25mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

Ro 61-8048 250mg  | ≥99%

CSNpharm

Ro 61-8048 is an inhibitor of kynurenine 3-hydroxylase which can potently and competitively inhibit kynurenine 3-monooxygenase with Ki value and IC50 value of 4.8 nM and 37 nM, respectively.

More Information Supplier Page

RO1138452 25mg  | ≥97%

CSNpharm

RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.

More Information Supplier Page

RO1138452 50mg  | ≥97%

CSNpharm

RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.

More Information Supplier Page

RO1138452 100mg  | ≥97%

CSNpharm

RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.

More Information Supplier Page

RO1138452 10mg  | ≥97%

CSNpharm

RO1138452 is a selective antagonist of prostacyclin (IP) receptor with pKi of 9.3 ± 0.1 in human platelets.

More Information Supplier Page

Rocaglamide 1mg  | ≥99%

CSNpharm

Rocaglamide, a naturally occurring product isolated from the herbs of Aglaia odorata Lour, induces apoptosis through the intrinsic death pathway in various human leukemia cell lines and in acute lymphoblastic leukemia, chronic myeloid leukemia and acute myeloid leukemia cells freshly isolated from patients.

More Information Supplier Page

Rocaglamide 5mg  | ≥99%

CSNpharm

Rocaglamide, a naturally occurring product isolated from the herbs of Aglaia odorata Lour, induces apoptosis through the intrinsic death pathway in various human leukemia cell lines and in acute lymphoblastic leukemia, chronic myeloid leukemia and acute myeloid leukemia cells freshly isolated from patients.

More Information Supplier Page

Rocaglamide 25mg  | ≥99%

CSNpharm

Rocaglamide, a naturally occurring product isolated from the herbs of Aglaia odorata Lour, induces apoptosis through the intrinsic death pathway in various human leukemia cell lines and in acute lymphoblastic leukemia, chronic myeloid leukemia and acute myeloid leukemia cells freshly isolated from patients.

More Information Supplier Page

Rocaglamide 10mg  | ≥99%

CSNpharm

Rocaglamide, a naturally occurring product isolated from the herbs of Aglaia odorata Lour, induces apoptosis through the intrinsic death pathway in various human leukemia cell lines and in acute lymphoblastic leukemia, chronic myeloid leukemia and acute myeloid leukemia cells freshly isolated from patients.

More Information Supplier Page

Rofecoxib 25mg  | ≥99%

CSNpharm

Rofecoxib is a potent inhibitor of the COX2-dependent production of PGE2 in human osteosarcoma cells with IC50 of 26±10 nM and Chinese hamster ovary cells expressing human COX-2 with IC50 of 18±7 nM.

More Information Supplier Page

Rofecoxib 100mg  | ≥99%

CSNpharm

Rofecoxib is a potent inhibitor of the COX2-dependent production of PGE2 in human osteosarcoma cells with IC50 of 26±10 nM and Chinese hamster ovary cells expressing human COX-2 with IC50 of 18±7 nM.

More Information Supplier Page

Roflumilast N-oxide 50mg  | ≥99%

CSNpharm

Roflumilast N-oxide, an active metabolite of roflumilast, is an inhibitor of phosphodiesterase 4 (PDE4). It can be combined with formoterol to enhance the antiinflammatory effect of dexamethasone.

More Information Supplier Page

Roflumilast N-oxide 25mg  | ≥99%

CSNpharm

Roflumilast N-oxide, an active metabolite of roflumilast, is an inhibitor of phosphodiesterase 4 (PDE4). It can be combined with formoterol to enhance the antiinflammatory effect of dexamethasone.

More Information Supplier Page

Roflumilast N-oxide 10mg  | ≥99%

CSNpharm

Roflumilast N-oxide, an active metabolite of roflumilast, is an inhibitor of phosphodiesterase 4 (PDE4). It can be combined with formoterol to enhance the antiinflammatory effect of dexamethasone.

More Information Supplier Page

Roflumilast N-oxide 5mg  | ≥99%

CSNpharm

Roflumilast N-oxide, an active metabolite of roflumilast, is an inhibitor of phosphodiesterase 4 (PDE4). It can be combined with formoterol to enhance the antiinflammatory effect of dexamethasone.

More Information Supplier Page

Roflumilast N-oxide 2mg  | ≥99%

CSNpharm

Roflumilast N-oxide, an active metabolite of roflumilast, is an inhibitor of phosphodiesterase 4 (PDE4). It can be combined with formoterol to enhance the antiinflammatory effect of dexamethasone.

More Information Supplier Page

Rolipram 50mg  | ≥99%

CSNpharm

Rolipram is a selective inhibitor of phosphodiesterases PDE 4, especially the PDE 4B with IC50 of 130 nM while IC50 for PDE4D is 240 nM, it’s an anti-inflammatory agent.

More Information Supplier Page

Rolipram 10mg  | ≥99%

CSNpharm

Rolipram is a selective inhibitor of phosphodiesterases PDE 4, especially the PDE 4B with IC50 of 130 nM while IC50 for PDE4D is 240 nM, it’s an anti-inflammatory agent.

More Information Supplier Page

Rolipram 100mg  | ≥99%

CSNpharm

Rolipram is a selective inhibitor of phosphodiesterases PDE 4, especially the PDE 4B with IC50 of 130 nM while IC50 for PDE4D is 240 nM, it’s an anti-inflammatory agent.

More Information Supplier Page

RON-IN-1 50mg  | ≥98%

CSNpharm

c-Met/RON Dual Kinase Inhibitor is a potent inhibitor against the kinase activities of HGF receptor c-Met and MSP (Macrophage Stimulating Protein) receptor RON with IC50 of 4 and 9 nM, respectively, and it is reported to inhibit NIH3T3 TRP-Met and U-87 tumor growth in mice in vivo in a dose-dependent manner.

More Information Supplier Page

RON-IN-1 100mg  | ≥98%

CSNpharm

c-Met/RON Dual Kinase Inhibitor is a potent inhibitor against the kinase activities of HGF receptor c-Met and MSP (Macrophage Stimulating Protein) receptor RON with IC50 of 4 and 9 nM, respectively, and it is reported to inhibit NIH3T3 TRP-Met and U-87 tumor growth in mice in vivo in a dose-dependent manner.

More Information Supplier Page

RON-IN-1 5mg  | ≥98%

CSNpharm

c-Met/RON Dual Kinase Inhibitor is a potent inhibitor against the kinase activities of HGF receptor c-Met and MSP (Macrophage Stimulating Protein) receptor RON with IC50 of 4 and 9 nM, respectively, and it is reported to inhibit NIH3T3 TRP-Met and U-87 tumor growth in mice in vivo in a dose-dependent manner.

More Information Supplier Page

RON-IN-1 10mg  | ≥98%

CSNpharm

c-Met/RON Dual Kinase Inhibitor is a potent inhibitor against the kinase activities of HGF receptor c-Met and MSP (Macrophage Stimulating Protein) receptor RON with IC50 of 4 and 9 nM, respectively, and it is reported to inhibit NIH3T3 TRP-Met and U-87 tumor growth in mice in vivo in a dose-dependent manner.

More Information Supplier Page

Ropinirole HCl 50mg  | ≥99%

CSNpharm

Ropinirole HCl selectively inhibit dopamine D2 receptor with Ki of 29 nM. It is used for the treatment of spontaneous parkinson’s disease.

More Information Supplier Page

Ropinirole HCl 250mg  | ≥99%

CSNpharm

Ropinirole HCl selectively inhibit dopamine D2 receptor with Ki of 29 nM. It is used for the treatment of spontaneous parkinson’s disease.

More Information Supplier Page

Ropinirole HCl 100mg  | ≥99%

CSNpharm

Ropinirole HCl selectively inhibit dopamine D2 receptor with Ki of 29 nM. It is used for the treatment of spontaneous parkinson’s disease.

More Information Supplier Page

Ropinirole HCl 25mg  | ≥99%

CSNpharm

Ropinirole HCl selectively inhibit dopamine D2 receptor with Ki of 29 nM. It is used for the treatment of spontaneous parkinson’s disease.

More Information Supplier Page

Roquinimex 10mg  | ≥98%

CSNpharm

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity and inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Roquinimex 25mg  | ≥98%

CSNpharm

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity and inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Roquinimex 5mg  | ≥98%

CSNpharm

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity and inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Roquinimex 50mg  | ≥98%

CSNpharm

Roquinimex is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity and inhibits angiogenesis and reduces the secretion of TNF alpha.

More Information Supplier Page

Rosavin 5mg  | ≥99%

CSNpharm

Rosavin, a natural product isolated and purified from the herb of Rhodiola rosea L. with anti-fatigue effect, decreases neovascular reaction on cutaneous angiogenesis induced in mice after grafting of syngeneic tumor cells.

More Information Supplier Page

Rosavin 100mg  | ≥99%

CSNpharm

Rosavin, a natural product isolated and purified from the herb of Rhodiola rosea L. with anti-fatigue effect, decreases neovascular reaction on cutaneous angiogenesis induced in mice after grafting of syngeneic tumor cells.

More Information Supplier Page